Antitrust lawsuit against Eli Lilly over chemotherapy drug stayed pending outcome of related patent case
MLex Summary: Eagle Pharmaceuticals' lawsuit accusing Eli Lilly of monopolizing the market for injections of the chemotherapy drug Pemetrexed was stayed by a federal judge, pending the outcome of related patent...To view the full article, register now.
Already a subscriber? Click here to view full article